Company Filing History:
Years Active: 2025
Title: Milan Shomenath Ganguly: Innovator in Influenza Vaccine Development
Introduction
Milan Shomenath Ganguly is a prominent inventor based in Pune, Maharashtra, India. He has made significant contributions to the field of vaccine development, particularly in the area of influenza vaccines. His innovative work has the potential to enhance public health by providing effective protection against influenza virus infections.
Latest Patents
Milan Shomenath Ganguly holds a patent for a "Stabilized live attenuated influenza vaccine compositions." This patent outlines compositions and methods for manufacturing and obtaining a live attenuated influenza vaccine (LAIV) that can be delivered intranasally. The LAIV strains are based on cold-adapted, temperature-sensitive, and attenuated phenotypes of master donor viruses (MDVs) containing the surface glycoprotein genes of wild-type pandemic or seasonal influenza strains. Notably, the use of eggs is avoided in large-scale vaccine manufacturing, and the purification process is devoid of chromatography steps. The LAIV composition includes one or more live attenuated influenza vaccine viruses and is free from polymers and surfactants. Milan's innovative approach aims to improve the efficacy and safety of influenza vaccines.
Career Highlights
Milan Shomenath Ganguly is associated with the Serum Institute of India Private Limited, a leading biotechnology company known for its vaccine production. His work at the institute has been instrumental in advancing vaccine technology and addressing public health challenges. With a focus on innovative solutions, Milan continues to contribute to the field of immunology and vaccine development.
Collaborations
Milan has collaborated with notable colleagues, including Rajeev Mhalasakant Dhere and Leena Ravindra Yeolekar. These collaborations have fostered a productive environment for research and innovation in vaccine development.
Conclusion
Milan Shomenath Ganguly's contributions to the field of influenza vaccine development exemplify the importance of innovation in public health. His patented work on live attenuated influenza vaccines represents a significant advancement in vaccine technology. Through his career at the Serum Institute of India, Milan continues to make strides in improving vaccine efficacy and accessibility.